Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.21, n°2 - March 2010 - Commentaries on harm reduction: looking back, looking forwards
Paru le :
01/03/2010
Année
2010
Page(s) :
91-144
Langue(s) :
Anglais
Thésaurus mots-clés
REDUCTION DES RISQUES ET DES DOMMAGES
Note de contenu :
CONTENTS:
Harm reduction: moving through the third decade, Stimson G. V., O'hare P., p. 91-93.
Public Health and the origins of the Mersey Model of Harm Reduction, Ashton J. R., Seymour H., p. 94-96.
Learning from HIV epidemics among injecting drug users, Jarlais D. C., p. 97-99.
Improving the data to strengthen the global response to HIV among people who inject drugs, Mathers B., Cook C., Degenhardt L., p. 100-102.
The Global Fund's leadership on harm reduction: 2002-2009, Atun R., Kazatchkine M., p. 103-106.
How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia, Bergenstrom A., Mcleod R., Sharma M., Mesquita F., Dorabjee J., Atun R., et al., p. 107-109.
Coexisting or conjoined: the growth of the international drug users' movement through participation with International Harm Reduction Association Conferences, Byrne J., Albert E. R., p. 110-111.
Young people and drugs: next generation of harm reduction, Merkinaite S., Grund J. P., Frimpong A., p. 112-114.
Islam and harm reduction, Kamarulzaman A., Saifuddeen S. M., p. 115-118.
Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier, Maguet O., Majeed M., p. 119-121.
Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings, Bruce R. D., p. 122-124.
Route transition interventions: potential public health gains from reducing or preventing injecting, Bridge J., p. 125-128.
Harm reduction policies for tobacco users, Gartner C., Hall W., p. 129-130.
Harm reduction healthcare: from an alternative to the mainstream platform?, Islam M. M., Day C. A., Conigrave K. M., p. 131-133.
Moving from a project to programmatic response: scaling up harm reduction in Asia, Chatterjee A., Sharma M., p. 134-136.
Normalization and harm reduction: research avenues and policy agendas, Erickson P. G., Hathaway A. D., p. 137-139.
Security, development and human rights: normative, legal and policy challenges for the international drug control system, Barrett D., p. 140-144.
Harm reduction: moving through the third decade, Stimson G. V., O'hare P., p. 91-93.
Public Health and the origins of the Mersey Model of Harm Reduction, Ashton J. R., Seymour H., p. 94-96.
Learning from HIV epidemics among injecting drug users, Jarlais D. C., p. 97-99.
Improving the data to strengthen the global response to HIV among people who inject drugs, Mathers B., Cook C., Degenhardt L., p. 100-102.
The Global Fund's leadership on harm reduction: 2002-2009, Atun R., Kazatchkine M., p. 103-106.
How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia, Bergenstrom A., Mcleod R., Sharma M., Mesquita F., Dorabjee J., Atun R., et al., p. 107-109.
Coexisting or conjoined: the growth of the international drug users' movement through participation with International Harm Reduction Association Conferences, Byrne J., Albert E. R., p. 110-111.
Young people and drugs: next generation of harm reduction, Merkinaite S., Grund J. P., Frimpong A., p. 112-114.
Islam and harm reduction, Kamarulzaman A., Saifuddeen S. M., p. 115-118.
Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier, Maguet O., Majeed M., p. 119-121.
Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings, Bruce R. D., p. 122-124.
Route transition interventions: potential public health gains from reducing or preventing injecting, Bridge J., p. 125-128.
Harm reduction policies for tobacco users, Gartner C., Hall W., p. 129-130.
Harm reduction healthcare: from an alternative to the mainstream platform?, Islam M. M., Day C. A., Conigrave K. M., p. 131-133.
Moving from a project to programmatic response: scaling up harm reduction in Asia, Chatterjee A., Sharma M., p. 134-136.
Normalization and harm reduction: research avenues and policy agendas, Erickson P. G., Hathaway A. D., p. 137-139.
Security, development and human rights: normative, legal and policy challenges for the international drug control system, Barrett D., p. 140-144.
Dépouillements
Ajouter le résultat à votre sélection
O. MAGUET ;
M. MAJEED
|
2010
Dans International Journal of Drug Policy (Vol.21, n°2, March 2010) Article : Périodique
Dans International Journal of Drug Policy (Vol.21, n°2, March 2010) Article : Périodique
Afghanistan has suffered decades of war, occupation and unrest. It is also the world's greatest producer of opium and drug production and trafficking account for a third of the total Afghan economy. Currently alongside the "War on Terrorism", th[...]